146 related articles for article (PubMed ID: 4149906)
1. [Antihistaminic-corticoid combinations in allergy].
Basomba Riba A; García Villalmanzo I; Baguena Candela J
Rev Clin Esp; 1973 Dec; 131(6):491-500. PubMed ID: 4149906
[No Abstract] [Full Text] [Related]
2. [Clinical evaluation of a new antihistaminic: HS-592].
von Bernath Z
Prensa Med Argent; 1971 Jul; 58(21):1071-5. PubMed ID: 4398545
[No Abstract] [Full Text] [Related]
3. A new antihistaminic drug (Tavegyl) in allergic diseases.
Hajós M
Ther Hung; 1971; 19(2):67-9. PubMed ID: 4152119
[No Abstract] [Full Text] [Related]
4. [Experience in the clinical use of Tavegyl in nose diseases--judgment of effectiveness by cross-over method].
Sugiura S
Jibiinkoka; 1971 Nov; 43(11):931-42. PubMed ID: 4401875
[No Abstract] [Full Text] [Related]
5. [Comparison of various new antihistaminics].
van der Bijl WJ
Ned Tijdschr Geneeskd; 1970 Feb; 114(8):358-60. PubMed ID: 4391853
[No Abstract] [Full Text] [Related]
6. [Pharmacological studies on the new antihistaminic Tavegil].
Römer D; Weidmann H
Med Welt; 1966 Dec; 51():2791-4. PubMed ID: 4382572
[No Abstract] [Full Text] [Related]
7. [Experience with a new antihistaminic in dermatology. Results of a clinical double blind trial].
Eberhartinger C; Ebner H
Wien Med Wochenschr; 1969 Sep; 119(38):630-2. PubMed ID: 4390510
[No Abstract] [Full Text] [Related]
8. [A new antihistaminic in the treatment of allergic diseases].
Basomba A; Oehling A
Rev Clin Esp; 1968 Jun; 109(5):417-22. PubMed ID: 4391259
[No Abstract] [Full Text] [Related]
9. [Case reports in clinical treatment with a synthetic antihistaminic: HS 592].
Giamperi M
Folia Allergol (Roma); 1971; 18(1):69-82. PubMed ID: 4397373
[No Abstract] [Full Text] [Related]
10. [Results of the use of a new synthetic antihistaminic (HS 592) in ophthalmology].
Laverone F
Ann Ottalmol Clin Ocul; 1968 Oct; 94(10):1217-24. PubMed ID: 4389858
[No Abstract] [Full Text] [Related]
11. [Clinical experience with HS-592 (a new antihistaminic) for so-called allergic rhinitis].
Baba S; Oashi M; Seno Y; Maruo T
Penn Dent J (Phila); 1970 Mar; 73(2):319-22. PubMed ID: 4192065
[No Abstract] [Full Text] [Related]
12. [Tavegyl in treatment of allergic skin diseases].
Kibler-Nockowska M
Wiad Lek; 1974 Apr; 27(7):645-8. PubMed ID: 4151284
[No Abstract] [Full Text] [Related]
13. Meclastine in hay fever.
Practitioner; 1972 Jun; 208(248):839-42. PubMed ID: 4402970
[No Abstract] [Full Text] [Related]
14. Clinical trials of a new antihistaminic HS 592.
Safwat FM
Rev Laryngol Otol Rhinol (Bord); 1972; 93(11):743-6. PubMed ID: 4146016
[No Abstract] [Full Text] [Related]
15. [Clinical evaluation of the antihistaminic activity of a new antihistaminic product with selective and non hypnotic action (HS 592)].
De Caro L; Rizzo SC
Folia Allergol (Roma); 1969; 16(3):234-48. PubMed ID: 4397213
[No Abstract] [Full Text] [Related]
16. [Clinical trial of a new antihistaminic for allergic rhinitis].
Axelsson A
Lakartidningen; 1970 Jul; 67(27):3105-8. PubMed ID: 4393901
[No Abstract] [Full Text] [Related]
17. [Determination of therapeutic effect of antihistaminics---clinical effect of HS 592].
Okuda M; Sekine K
Jibiinkoka; 1970 Jul; 42(7):555-7. PubMed ID: 4394032
[No Abstract] [Full Text] [Related]
18. [Allergic rhinitis treated with Tavegyl].
Ronning-Arnesen A
Tidsskr Nor Laegeforen; 1971 Nov; 91(32):2329-31. PubMed ID: 4399793
[No Abstract] [Full Text] [Related]
19. [Effect of a new oral remedy for a cold (HSP 525 A) on flow resistance of the nose].
Schibli RA; Radielovic P; Bühlmann AA
Int J Clin Pharmacol; 1973 Aug; 8(1):58-63. PubMed ID: 4146962
[No Abstract] [Full Text] [Related]
20. [Evaluation of the efficacy of anti-inflammatory drugs].
Hatano H
Nihon Hifuka Gakkai Zasshi; 1972 Sep; 82(9):835-42. PubMed ID: 4405666
[No Abstract] [Full Text] [Related]
[Next] [New Search]
